LPL Financial
RIGL icon

LPL Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

LPL Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,022
Closed -$44.7K – 5112
2024
Q1 		$44.7K Buy
3,022
+3
+0.1% +$40 ﹤0.01% 4779
2023
Q4 		$43.8K Buy
3,019
+301
+11% +$3.08K ﹤0.01% 4667
2023
Q3 		$29.3K Hold
2,718
– – ﹤0.01% 4576
2023
Q2 		$35.1K Hold
2,718
– – ﹤0.01% 4467
2023
Q1 		$35.9K Hold
2,718
– – ﹤0.01% 4356
2022
Q4 		$40.8K Sell
2,718
-113
-4% -$1.04K ﹤0.01% 4295
2022
Q3 		$33K Sell
2,831
-768
-21% -$10.4K ﹤0.01% 4281
2022
Q2 		$41K Hold
3,599
– – ﹤0.01% 4263
2022
Q1 		$108K Hold
3,599
– – ﹤0.01% 3961
2021
Q4 		$95K Buy
3,599
+1,042
+41% +$31.4K ﹤0.01% 4148
2021
Q3 		$93K Buy
2,557
+948
+59% +$37.3K ﹤0.01% 4160
2021
Q2 		$70K Buy
+1,609
New +$60.7K ﹤0.01% 4110
2020
Q1 		– Sell
-1,150
Closed -$25K – 3389
2019
Q4 		$25K Hold
1,150
– – ﹤0.01% 3302
2019
Q3 		$22K Hold
1,150
– – ﹤0.01% 3250
2019
Q2 		$30K Sell
1,150
-200
-15% -$4.51K ﹤0.01% 3229
2019
Q1 		$35K Hold
1,350
– – ﹤0.01% 3135
2018
Q4 		$31K Buy
1,350
+200
+17% +$5.64K ﹤0.01% 3025
2018
Q3 		$37K Hold
1,150
– – ﹤0.01% 3186
2018
Q2 		$33K Buy
+1,150
New +$40.9K ﹤0.01% 3161

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

LPL Financial's RIGL Position: Q2 2024 in Review

LPL Financial sold out of Rigel Pharmaceuticals (RIGL) in Q2 2024, closing a stake of 3,022 shares — an estimated $44.7K sold.

LPL Financial first reported a position in RIGL in Q2 2018 and held it in 19 quarters. The position peaked at $108K in Q1 2022. 91 funds tracked by Wall St. Rank hold RIGL as of Q2 2024.

  • LPL Financial reported no remaining Rigel Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • LPL Financial sold 3,022 Rigel Pharmaceuticals shares in Q2 2024, an estimated $44.7K.
  • LPL Financial first reported a position in Rigel Pharmaceuticals in Q2 2018 and held it in 19 quarters.
  • LPL Financial's Rigel Pharmaceuticals position peaked at $108K in Q1 2022.
  • 91 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2024.

Based on LPL Financial's 13F filing for Q2 2024, filed 7 Aug 2024.